Document Detail


The Potential Role of Erythropoietin as a Pleiotropic Agent in Post-cardiac Arrest Syndrome.
MedLine Citation:
PMID:  21486214     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Sudden cardiac arrest is a leading cause of death worldwide with survival rates still remaining suboptimal. Unfortunately, most cardiac arrest patients, who achieve return of spontaneous circulation (ROSC), develop a multi-faceted post-cardiac arrest syndrome, including post-cardiac arrest brain injury, myocardial dysfunction, and systemic ischemia/reperfusion response. Erythropoietin (EPO), the principal hematopoietic hormone regulating erythropoiesis, exhibits diverse cellular effects in nonhematopoietic tissues. Due to its anti-apoptotic, anti-inflammatory, and anti-oxidant properties, as well as its angiogenic action, EPO plays a role in neuroprotection and cardioprotection. In this regard, EPO represents a promising agent in the cardiac arrest setting, based on a therapeutic strategy that focuses on the post-resuscitation phase. This review aims to provide a comprehensive account of EPO's role in the treatment of each individual component of post-cardiac arrest syndrome.
Authors:
Theodoros Xanthos; Panagiotis V S Vasileiou; Sotirios Kakavas; Aggeliki Syggelou; Nicoletta Iacovidou
Related Documents :
1394414 - Atrial septal puncture technique in percutaneous transvenous mitral commissurotomy: mit...
15670524 - Rheumatic mitral stenosis presenting as acute abdominal aortic occlusion and foot drop.
3339164 - Mitral balloon valvuloplasty for mitral restenosis after surgical commissurotomy.
12202874 - Impact of cox maze procedure on outcome in patients with atrial fibrillation and mitral...
22331174 - Successful radiofrequency catheter ablation of common atrial flutter at the bottom of a...
6457544 - Thallium myocardial perfusion scans for the assessment of right ventricular hypertrophy...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-13
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Anatomy, University of Athens, Medical School, P.O. Box 11527, 75 M. Asias, Goudi, Athens, Greece. theodorosxanthos@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular modeling used to evaluate CYP2C9-dependent metabolism: homology modeling, molecular dynami...
Next Document:  Drug Resistance: Challenges to Effective Therapy.